SelenoPrecise

SelenoPrecise is a pharmaceutical-grade, patented organic high-selenium yeast product developed by Pharma Nord. It contains a standardized range of selenium species, including Se-methylselenocysteine, and is characterized by high bioavailability (approximately 89%). As a nutraceutical, it functions by providing the essential trace element selenium, which is incorporated into selenoproteins and antioxidant enzymes such as glutathione peroxidase. It has been investigated in clinical trials, notably by the Karolinska Institutet, for its potential to reduce liver fibrosis and disease activity in patients with chronic hepatitis C, and in the KiSel-10 study for reducing cardiovascular mortality when combined with Coenzyme Q10.

Brand names

SelenoPrecise

Other names

selenium yeaststandardized selenium yeastselenium-enriched yeast